Health Care & Life Sciences » Biotechnology | Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
 EUR0.43
Market Cap
 EUR6.89 B
Shares Outstanding
 90.47 M
Public Float
 75.36 M
Neurocrine Biosciences Inc.
Stock Exchange NASDAQ Stock Market
EPS
 $0.47
Market Cap
 $7.78 B
Shares Outstanding
 91.29 M
Public Float
 89.08 M

Profile

Address
12780 El Camino Real
San Diego California 92130
United States
Employees -
Website http://www.neurocrine.com
Updated 07/08/2019
Neurocrine Biosciences, Inc. operates as a product based bio-pharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company product includes INGREZZA.

Financials

View All
Created with Highcharts 5.0.14Neurocrine Biosciences Inc.Net Income. Fiscal year is January-December. All values USD Thousands.46 09046 09060 54260 54288 92988 929141 090141 090142 542142 54221 11121 111201320142015201620172018025k50k75k100k125k150k
Created with Highcharts 5.0.14Neurocrine Biosciences Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.2 9192 9190019 76919 76915 00015 000161 626161 626451 240451 2402013201420152016201720180100k200k300k400k500k

Kevin Charles Gorman
Chief Executive Officer & Director
William H. Rastetter
Chairman
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.